Open in web browser

You are subscribed to the FormularyWatch eNews.

FormularyWatch

Share

eNews Subscribe

More Subscriptions

FORMULARY WATCH

Antibiotics & Generics

5 reasons antibiotic resistance is a health crisis

Overuse and misuse of antibiotics has led to a public health crisis—a crisis we must pay attention to now, according to Consumer Reports. Here's why.

ADVERTISEMENT

Idiopathic Pulmonary Fibrosis (IPF)

IPF is the progressive formation of thick or scarred tissue in the lungs, resulting in loss of oxygen. While there is currently no known cause, continued research seeks to find an answer, alongside improved diagnosis and treatment options. Learn More

FDA approves generic Comtan tablets for Parkinson's

FDA has approved Aurobindo’s entacapone tablets USP, 200 mg, the generic equivalent to Novartis’ Comtan tablets 200 mg. Harvard Medical School expert insights

Continuing Education

MTM essentials for COPD management: Part 1

This month's CE activity is part of a CPE series, Medication Therapy Management for the Patient with Respiratory Disease. From April 2015 through December 2015, pharmacists can earn up to 18 hours of CPE credit with 9 monthly knowledge-based activities from the University of Connecticut School of Pharmacy and Drug Topics.

The goal of this month's activity is to assist pharmacists in understanding the pathophysiology and pharmacologic treatment of COPD and to discuss how COPD is similar to and different from other chronic respiratory disorders.

To read and print the article with TEST questions, click here.

To proceed to the online exams and earn up to 2 CPE credits, click here to log in with the Session Code: 15DT31-KTJ28.

To login to the Online CE Center, go to:
https://web2.uconn.edu/pharmacyce/login.php.
To review your registration page or to register, go to:
https://web2.uconn.edu/pharmacyce/program_register.php.
For a full list of courses, go to:
http://pharmacy.uconn.edu/academics/ce/drug-topics-and-uconn-ce/

EDITOR'S PICK

5 drugs headed for $1B or more in sales by 2020

Global prescription drug sales should reach nearly $1 trillion by 2020, thanks in part to FDA approvals of breakthrough drugs for cancer, hepatitis C and other diseases, according to a new report. Hep C, melanoma drug top list

July 1, 2015

Related Articles

BLOG: Time to show and tell about antibiotic stewardship programs

FDA opens up generic competition

Resources

Get the latest FormularyWatch updates on drug approvals, current studies, and other findings.

Click for the latest Clinical News

Click here to contact Editorial. Sales, Reprints, Classified questions? Click here to contact the Sales Team.

ModernMedicine logo
UBM  logo

UBM MEDICA